{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:55:56Z","timestamp":1762505756711},"reference-count":152,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.2217\/imt.11.46","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T19:01:21Z","timestamp":1304967681000},"page":"653-671","source":"Crossref","is-referenced-by-count":18,"title":["Re-Inventing Intratumoral Immunotherapy for Melanoma"],"prefix":"10.1080","volume":"3","author":[{"given":"Pierre L","family":"Triozzi","sequence":"first","affiliation":[{"name":"Taussig Cancer Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue\/R40, Cleveland, OH44195, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph J","family":"Tuthill","sequence":"additional","affiliation":[{"name":"Melanoma Program, The Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Borden","sequence":"additional","affiliation":[{"name":"Melanoma Program, The Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,5,9]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002620100216"},{"issue":"1","key":"e_1_3_3_3_2_1","first-page":"158","article-title":"Immunological factors which influence response to immunotherapy in malignant melanoma.","volume":"68","author":"Morton DL","year":"1970","unstructured":"Morton DL , EilberFR, MalmgrenRA, WoodWC: Immunological factors which influence response to immunotherapy in malignant melanoma.Surgery68(1) , 158\u2013164 (1970).","journal-title":"Surgery"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5708.512"},{"key":"e_1_3_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92103-X"},{"key":"e_1_3_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.10.032"},{"key":"e_1_3_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjps.1998.3050"},{"key":"e_1_3_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799"},{"key":"e_1_3_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01439.x"},{"key":"e_1_3_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4610"},{"key":"e_1_3_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1309\/WBF7-N8KH-71KT-RVQ9"},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-199212000-00022"},{"key":"e_1_3_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e3181b34a19"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1992.tb00070.x"},{"key":"e_1_3_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603763"},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.0.CO;2-3"},{"key":"e_1_3_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2484"},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.02.018"},{"key":"e_1_3_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.5829"},{"key":"e_1_3_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04046-0"},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1673"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2008.03.004"},{"key":"e_1_3_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020161"},{"key":"e_1_3_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(96)80118-8"},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1054\/jpai.2002.125184"},{"key":"e_1_3_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.11.016"},{"key":"e_1_3_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115835"},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.1.225"},{"key":"e_1_3_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.4.2085"},{"key":"e_1_3_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0103026"},{"key":"e_1_3_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2006.05.004"},{"key":"e_1_3_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000131944.52354.63"},{"key":"e_1_3_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66410-5"},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000073852.24341.4a"},{"key":"e_1_3_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2002.00415.x"},{"key":"e_1_3_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.116.5.1407"},{"key":"e_1_3_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35678-1"},{"key":"e_1_3_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2003.12.003"},{"key":"e_1_3_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2007.02575.x"},{"key":"e_1_3_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02071.x"},{"key":"e_1_3_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197410000-00029"},{"issue":"5","key":"e_1_3_3_3_41_1","first-page":"659","article-title":"Regression of intradermal malignant melanoma after intralesional injection of Mycobacterium bovis strain BCG.","volume":"56","author":"Nathanson L","year":"1972","unstructured":"Nathanson L : Regression of intradermal malignant melanoma after intralesional injection of Mycobacterium bovis strain BCG.Cancer Chemother. Rep.56(5) , 659\u2013665 (1972).","journal-title":"Cancer Chemother. Rep."},{"key":"e_1_3_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1993.tb00989.x"},{"key":"e_1_3_3_3_43_1","unstructured":"Morton DL HuntKK BauerRL LeeJD: Clinical application using intralesional therapy. In: Biologic Therapy of Cancer. De Vita V Hellman S Rosenberg SA (Eds). JB Lippincott Company PA USA 627\u2013642 (1991)."},{"key":"e_1_3_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197310182891603"},{"key":"e_1_3_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)91455-5"},{"key":"e_1_3_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1159\/000225349"},{"key":"e_1_3_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197812)42:6<2648::AID-CNCR2820420621>3.0.CO;2-J"},{"key":"e_1_3_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197510)36:4<1305::AID-CNCR2820360417>3.0.CO;2-#"},{"key":"e_1_3_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200411000-00080"},{"key":"e_1_3_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20166"},{"key":"e_1_3_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197503)35:3<756::AID-CNCR2820350331>3.0.CO;2-Z"},{"key":"e_1_3_3_3_52_1","first-page":"152","article-title":"Effect of BCG immunotherapy on alloantigen-induced blastogenesis and cytotoxicity of lymph node lymphocytes in patients with melanoma.","volume":"30","author":"Callery CD","year":"1979","unstructured":"Callery CD , MortonDL, GolubSH: Effect of BCG immunotherapy on alloantigen-induced blastogenesis and cytotoxicity of lymph node lymphocytes in patients with melanoma.Surg. Forum.30 , 152\u2013154 (1979).","journal-title":"Surg. Forum."},{"key":"e_1_3_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053007"},{"key":"e_1_3_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.9.5530"},{"key":"e_1_3_3_3_55_1","unstructured":"Wang W EdingtonH RaoU JukicD WangH KirkwoodJM: Effects of high-dose IFN\u03b1 on FOXP3 expression in lymph nodes of melanoma patients. Presented at: The 98th AACR Annual Meeting. CA USA 14\u201318 April 2007 (Abstract 4306)."},{"key":"e_1_3_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.3.428"},{"key":"e_1_3_3_3_57_1","unstructured":"Ishihara K HayasakaK. Yamamoto A Hasegawe F: Clinical response of patients with malignant skin neoplasia to intralesional treatment with three types of interferons. In: Interferons. Kishida T (Ed.). ISIFN Kyoto Japan 222\u2013227 (1983)."},{"key":"e_1_3_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880315)61:6<1071::AID-CNCR2820610603>3.0.CO;2-T"},{"key":"e_1_3_3_3_59_1","first-page":"48","article-title":"Potential applications of the interferons in oncology: lessons drawn from studies of human melanoma.","volume":"13","author":"Kirkwood J","year":"1986","unstructured":"Kirkwood J , ErnstoffM: Potential applications of the interferons in oncology: lessons drawn from studies of human melanoma.Semin. Oncol.13(3 Suppl 2) , 48\u201356 (1986).","journal-title":"Semin. Oncol."},{"issue":"1","key":"e_1_3_3_3_60_1","first-page":"16","article-title":"Intralesional therapy of melanoma metastases with recombinant interferon-\u03b2.","volume":"43","author":"Fierlbeck G","year":"1992","unstructured":"Fierlbeck G , d\u2018HoedtB, StroebelW, StutteH, BogenschutzO, RassnerG: Intralesional therapy of melanoma metastases with recombinant interferon-\u03b2.Hautarzt.43(1) , 16\u201321 (1992).","journal-title":"Hautarzt."},{"key":"e_1_3_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1998.tb02460.x"},{"key":"e_1_3_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2006.06054.x"},{"key":"e_1_3_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0841-6"},{"key":"e_1_3_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200312000-00011"},{"issue":"1","key":"e_1_3_3_3_65_1","first-page":"152","article-title":"Evaluation of rIFN-\u03b3 in the treatment of lymphoma and melanoma of the skin by systemic and intralesional administration.","volume":"14","author":"Jimbow K","year":"1987","unstructured":"Jimbow K , YamanaK, IshidaO, KawamuraM, ItoY, MaedaK: Evaluation of rIFN-\u03b3 in the treatment of lymphoma and melanoma of the skin by systemic and intralesional administration.Gan To Kagaku Ryoho14(1) , 152\u2013158 (1987).","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_3_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2399"},{"key":"e_1_3_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80566-X"},{"key":"e_1_3_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.1998.0115"},{"key":"e_1_3_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910510524"},{"key":"e_1_3_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-004-0627-4"},{"key":"e_1_3_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601320"},{"key":"e_1_3_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25156"},{"key":"e_1_3_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(09)71905-2"},{"key":"e_1_3_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.15.3477"},{"key":"e_1_3_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1614"},{"key":"e_1_3_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06925.x"},{"key":"e_1_3_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199606000-00008"},{"key":"e_1_3_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.10.1276"},{"key":"e_1_3_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00254.x"},{"key":"e_1_3_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.0705"},{"key":"e_1_3_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.10.1.69"},{"key":"e_1_3_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2009.01227.x"},{"key":"e_1_3_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06176.x"},{"key":"e_1_3_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.4.510"},{"key":"e_1_3_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000211531.33670.94"},{"key":"e_1_3_3_3_86_1","unstructured":"Steinmann A FunkJO BergerT et al.: First experiences with the topical immune response modifier imiquimod for the treatment of cutaneous melanoma metastases. Presented at: The 30th Annual Meeting of the European Society for Dermatological Research. Berlin Germany 21\u201323 September 2000 (Abstract 356)."},{"key":"e_1_3_3_3_87_1","first-page":"244","article-title":"Locoregional cutaneous metastases of malignant melanoma and their management.","volume":"30","author":"Wolf IH","year":"2004","unstructured":"Wolf IH , RichtigE, KoperaD, KerlH: Locoregional cutaneous metastases of malignant melanoma and their management.Dermatol. Surg.30(2 Pt 2) , 244\u2013247 (2004).","journal-title":"Dermatol. Surg."},{"key":"e_1_3_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2009.01290.x"},{"key":"e_1_3_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07664.x"},{"issue":"6","key":"e_1_3_3_3_90_1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1610-0387.2009.07038.x","article-title":"Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy.","volume":"7","author":"Heber G","year":"2009","unstructured":"Heber G , HelbigD, P\u00f6nitzschI, WetzigT, HarthW, SimonJC: Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy.J. Dtsch. Dermatol. Ges.7(6) , 534\u2013536 (2009).","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"e_1_3_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000063904"},{"key":"e_1_3_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.3.273"},{"issue":"3","key":"e_1_3_3_3_93_1","first-page":"555","volume":"43","author":"Steinmann A","year":"2000","unstructured":"Steinmann A , FunkJO, SchulerG, von den Driesch P: Topical imiquimod treatment of a cutaneous melanoma metastasis. J. Am. Acad. Dermatol.43(3) , 555\u2013556 (2000).","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0007-0963.2004.05898.x"},{"key":"e_1_3_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.488811.x"},{"key":"e_1_3_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08709.x"},{"key":"e_1_3_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.3.1670"},{"key":"e_1_3_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.9129"},{"key":"e_1_3_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318174a4df"},{"key":"e_1_3_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.460101.x"},{"key":"e_1_3_3_3_101_1","first-page":"71","article-title":"Activation of peripheral T-lymphocytes in metastatic melanoma with combined immune chemotherapy with dinitrochlorobenzene (DNCB) locally and dacarbazine (DTIC) systemically \u2013 observations of two cases.","author":"Trcka J","year":"1996","unstructured":"Trcka J , K\u00e4mpgenE, Br\u00f6ckerEB: Activation of peripheral T-lymphocytes in metastatic melanoma with combined immune chemotherapy with dinitrochlorobenzene (DNCB) locally and dacarbazine (DTIC) systemically \u2013 observations of two cases.Z. Hautkrankheiten71 (1996) (Abstract 877).","journal-title":"Z. Hautkrankheiten"},{"key":"e_1_3_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089168807400504"},{"key":"e_1_3_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197806)41:6<2456::AID-CNCR2820410654>3.0.CO;2-B"},{"key":"e_1_3_3_3_104_1","first-page":"293","article-title":"Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years).","volume":"4","author":"Illig L","year":"1984","unstructured":"Illig L , PaulE, BodekerRH: Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years).Anticancer Res.4(4\u20135) , 293\u2013298 (1984).","journal-title":"Anticancer Res."},{"key":"e_1_3_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-002-0292-4"},{"key":"e_1_3_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-006-0182-9"},{"key":"e_1_3_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.12.018"},{"key":"e_1_3_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2283"},{"key":"e_1_3_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-007-9089-3"},{"key":"e_1_3_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.227"},{"key":"e_1_3_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.6.839"},{"key":"e_1_3_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.1.341"},{"key":"e_1_3_3_3_113_1","first-page":"21","article-title":"A controlled, randomized Phase III trial comparing the response to dacarbazine with and without Allovectin-7 in patients with metastatic melanoma.","author":"Richards J","year":"2002","unstructured":"Richards J , ThompsonJ, AtkinsMB et al.: A controlled, randomized Phase III trial comparing the response to dacarbazine with and without Allovectin-7 in patients with metastatic melanoma.Proc. Am. Soc. Clin. Oncol.21 (2002) (Abstract 1380).","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"e_1_3_3_3_114_1","first-page":"1237","article-title":"Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report.","volume":"18","author":"Moller P","year":"1998","unstructured":"Moller P , WittigB, SchadendorfD: Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report.Anticancer Res.18(2B) , 1237\u20131241 (1998).","journal-title":"Anticancer Res."},{"issue":"5","key":"e_1_3_3_3_115_1","first-page":"491","article-title":"Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot study.","volume":"3","author":"Adler A","year":"1984","unstructured":"Adler A , SteinJA, KedarE, NaorD, WeissDW: Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot study.J. Biol. Response Mod.3(5) , 491\u2013500 (1984).","journal-title":"J. Biol. Response Mod."},{"key":"e_1_3_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1485"},{"key":"e_1_3_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1080\/14653240902923146"},{"key":"e_1_3_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1993.48"},{"key":"e_1_3_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1879"},{"key":"e_1_3_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001215)89:12<2646::AID-CNCR18>3.0.CO;2-A"},{"key":"e_1_3_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22551"},{"key":"e_1_3_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700441"},{"key":"e_1_3_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.22.8694"},{"key":"e_1_3_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.9793"},{"key":"e_1_3_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4296"},{"key":"e_1_3_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21557"},{"key":"e_1_3_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700066"},{"key":"e_1_3_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24624"},{"key":"e_1_3_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2006.17.239"},{"key":"e_1_3_3_3_130_1","first-page":"17","article-title":"Intratumoral administration of cananrypox virus expressing human GM-CSF gene (ALVAC-GM-CSF) in cancer patients: results of a Phase I study.","author":"Bonnet MC","year":"1998","unstructured":"Bonnet MC , DummerR, LejeuneF et al.: Intratumoral administration of cananrypox virus expressing human GM-CSF gene (ALVAC-GM-CSF) in cancer patients: results of a Phase I study.Proc. Am. Soc. Clin. Oncol.17 (1998) (Abstract 1657).","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"e_1_3_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e3282f702cf"},{"key":"e_1_3_3_3_132_1","first-page":"1","article-title":"Intratumoral administration of cananrypox virus expressing human IL-2 gene (ALVAC-IL-2) in cancer patients: results of a Phase I study.","author":"Lienard D","year":"1998","unstructured":"Lienard D , LejeuneFJ, DummerR et al.: Intratumoral administration of cananrypox virus expressing human IL-2 gene (ALVAC-IL-2) in cancer patients: results of a Phase I study.Proc. Am. Soc. Clin. Oncol.1 (1998) (Abstract 1655).","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"e_1_3_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00491-6"},{"key":"e_1_3_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.91"},{"key":"e_1_3_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700568"},{"key":"e_1_3_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.09.019"},{"key":"e_1_3_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.09.021"},{"key":"e_1_3_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.32"},{"key":"e_1_3_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700224"},{"key":"e_1_3_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.3675"},{"key":"e_1_3_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0809-6"},{"issue":"8","key":"e_1_3_3_3_142_1","first-page":"2285","article-title":"Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7\/\u03b22-microglobulin DNA-liposome complex, in patients with metastatic melanoma.","volume":"7","author":"Stopeck AT","year":"2001","unstructured":"Stopeck AT , JonesA, HershEM et al.: Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7\/\u03b22-microglobulin DNA-liposome complex, in patients with metastatic melanoma.Clin. Cancer Res.7(8) , 2285\u20132291 (2001).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.2165\/00024669-200504030-00001"},{"key":"e_1_3_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.cmr.0000232299.44902.41"},{"key":"e_1_3_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e3283390711"},{"key":"e_1_3_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.35"},{"key":"e_1_3_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7701064"},{"key":"e_1_3_3_3_148_1","article-title":"Phase I trial of IL-2 plasmid DNA with electroporation in metastatic melanoma.","volume":"25","author":"Richards JM","year":"2007","unstructured":"Richards JM , GonzalezR, SchwarzenbergerP et al.: Phase I trial of IL-2 plasmid DNA with electroporation in metastatic melanoma.Proc. ASCO25(S18) , (2007) (Abstract 8578).","journal-title":"Proc. ASCO"},{"key":"e_1_3_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.6794"},{"key":"e_1_3_3_4_2_1","unstructured":"National Comprehensive Cancer Network www.nccn.org"},{"key":"e_1_3_3_4_3_1","unstructured":"BioVex: testing a new approach in advanced melanoma and locally advanced squamous cell carcinoma of the head and neck www.oncovexgmcsf.com"},{"key":"e_1_3_3_4_4_1","unstructured":"Vical clinical trials www.vical.com\/clinical-trials"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.11.46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T20:02:33Z","timestamp":1715976153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.11.46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":152,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.2217\/imt.11.46"],"URL":"https:\/\/doi.org\/10.2217\/imt.11.46","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}